Total Payments
$9,387
2024 Payments
$1,942
Companies
46
Transactions
402
Medicare Patients
2,469
Medicare Billing
$248,658
Payment Breakdown by Category
Food & Beverage$8,560 (91.2%)
Travel$822.06 (8.8%)
Education$5.11 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,560 | 398 | 91.2% |
| Travel and Lodging | $822.06 | 3 | 8.8% |
| Education | $5.11 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,663 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $937.89 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $680.72 | 11 | $0 (2022) |
| ABBVIE INC. | $632.23 | 47 | $0 (2024) |
| Gilead Sciences, Inc. | $527.42 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $476.58 | 19 | $0 (2024) |
| Novo Nordisk Inc | $457.00 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $393.79 | 7 | $0 (2021) |
| PFIZER INC. | $383.79 | 42 | $0 (2024) |
| Amgen Inc. | $317.77 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,942 | 53 | Novartis Pharmaceuticals Corporation ($1,106) |
| 2023 | $550.80 | 31 | Gilead Sciences, Inc. ($71.66) |
| 2022 | $1,095 | 52 | Gilead Sciences, Inc. ($190.05) |
| 2021 | $859.72 | 49 | AbbVie Inc. ($230.78) |
| 2020 | $579.81 | 23 | Janssen Pharmaceuticals, Inc ($120.40) |
| 2019 | $1,058 | 31 | AstraZeneca Pharmaceuticals LP ($242.49) |
| 2018 | $1,009 | 48 | Boehringer Ingelheim Pharmaceuticals, Inc. ($178.69) |
| 2017 | $2,293 | 115 | AstraZeneca Pharmaceuticals LP ($347.93) |
All Payment Transactions
402 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Oncology | ||||||
| 12/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.43 | General |
| 10/03/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $126.00 | General |
| Category: COVID-19 | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $39.59 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/22/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $572.30 | General |
| 09/22/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $235.69 | General |
| 09/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $111.15 | General |
| 09/22/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $14.07 | General |
| 09/21/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $172.53 | General |
| 09/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: Cardiovascular | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 434 | 745 | $97,547 | $46,335 |
| 2022 | 15 | 780 | 1,398 | $162,115 | $84,432 |
| 2021 | 11 | 481 | 837 | $99,150 | $47,679 |
| 2020 | 18 | 774 | 1,341 | $147,850 | $70,211 |
Total Patients
2,469
Total Services
4,321
Medicare Billing
$248,658
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 209 | $25,520 | $9,677 | 37.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 113 | $12,329 | $6,987 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 80 | $12,600 | $5,870 | 46.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 52 | $9,317 | $5,337 | 57.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 36 | 122 | $6,304 | $4,793 | 76.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 64 | 67 | $9,020 | $4,180 | 46.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 39 | $10,551 | $3,290 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 25 | 25 | $5,000 | $3,135 | 62.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 21 | $5,791 | $2,634 | 45.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 17 | $1,115 | $432.55 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 182 | 356 | $42,720 | $20,724 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 149 | $23,095 | $12,338 | 53.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 89 | 380 | $19,000 | $11,516 | 60.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 58 | 137 | $13,645 | $7,599 | 55.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $10,200 | $6,488 | 63.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 42 | 42 | $7,350 | $4,437 | 60.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 71 | 72 | $9,430 | $4,018 | 42.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 18 | $7,200 | $3,883 | 53.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 49 | 50 | $6,500 | $3,878 | 59.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 38 | 38 | $7,260 | $3,108 | 42.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 35 | $9,675 | $2,646 | 27.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $3,920 | $2,031 | 51.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,280 | $1,093 | 85.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $660.00 | $613.40 | 92.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 18 | $180.00 | $61.58 | 34.2% |
About Dr. Khalid Ahmed, MD
Dr. Khalid Ahmed, MD is a Internal Medicine healthcare provider based in Flint, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619965175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalid Ahmed, MD has received a total of $9,387 in payments from pharmaceutical and medical device companies, with $1,942 received in 2024. These payments were reported across 402 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,560).
As a Medicare-enrolled provider, Ahmed has provided services to 2,469 Medicare beneficiaries, totaling 4,321 services with total Medicare billing of $248,658. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Flint, MI
- Active Since 10/10/2005
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619965175
Products in Payments
- JARDIANCE (Drug) $660.77
- FARXIGA (Drug) $597.33
- ENTRESTO (Drug) $557.08
- VRAYLAR (Drug) $412.65
- INVOKANA (Drug) $288.23
- REXULTI (Drug) $258.10
- Veklury (Drug) $232.00
- NURTEC ODT (Drug) $221.93
- TOUJEO (Drug) $203.90
- UBRELVY (Drug) $202.83
- SYMBICORT (Drug) $194.30
- TRULICITY (Drug) $179.69
- Tresiba (Drug) $163.80
- UTIBRON (Drug) $156.49
- Aimovig (Biological) $154.30
- ELIQUIS (Drug) $148.97
- LONHALA MAGNAIR (Drug) $122.04
- SOLIQUA (Drug) $121.84
- iPro2 (Device) $119.48
- EUCRISA (Drug) $119.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Flint
Henry Mendoza, M.d, M.D
Internal Medicine — Payments: $65,197
Internal Medicine $65,197
Dr. Ahmed Arif, Md, MD
Internal Medicine — Payments: $50,691
Internal Medicine $50,691
Dr. Ryan Malek, D.o, D.O
Internal Medicine — Payments: $17,649
Internal Medicine $17,649
Dr. Kazem Hak, M.d, M.D
Internal Medicine — Payments: $16,743
Internal Medicine $16,743
Kamal Kassem, Md, MD
Internal Medicine — Payments: $15,984
Internal Medicine $15,984
Dr. Miguel Perez-Pascual, M.d, M.D
Internal Medicine — Payments: $14,323
Internal Medicine $14,323